AH Bio Fund IV, L.P.
Late investment period
Late investment period: first sale Jan 2022, per Form D (fund age approximates vintage)
No contact route found yet.
- Vintage
- 2022
- Fund size
- $1500M (Form D)
- Stages
- Seed, Growth
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
Invests in seed to growth-stage technology companies across AI, bio and healthcare, consumer, crypto, enterprise, fintech, games, infrastructure, and companies building toward American dynamism.Inferred from the firm's website
02 · Initial check
$15M to $25M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Marc Andreessen, Managing Member of the General Partner
- Ben Horowitz, Managing Member of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideAndreessen Horowitz invests in seed to growth-stage technology companies across AI, bio and healthcare, consumer, crypto, enterprise, fintech, games, infrastructure, and companies building toward American dynamism.
We invest in seed to venture to growth-stage technology companies, across AI, bio + healthcare, consumer, crypto, enterprise, fintech, games, infrastructure, and companies building toward American dynamism.
https://a16z.com/about/
06 · Sources
Last verified: Oct 28, 2026